Norcenane sesquiterpenes, pharmaceutical composition, preparation method and application thereof
A compound and drug technology, applied in the field of natural medicinal chemistry, can solve problems such as no medicinal records
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] Extraction, separation and purification of compound 1-9 of the present invention:
[0041]Dry the rhizomes (19 kg) of the genus Chiapodium in the shade, crush them to 30 meshes, extract them three times with 95% methanol at room temperature, 70 L each time for 24 hours, combine the extracts, and concentrate the extracts under reduced pressure to obtain Suspend the extract with an appropriate amount of water, and distribute it several times with ethyl acetate to obtain an ethyl acetate extract (1.5 kg). The extract is dissolved in an appropriate amount of chloroform / acetone and mixed with silica gel 80-100 mesh, and then mixed with 650 G silica gel 200-300 mesh was used for column chromatography, and the gradient elution was carried out with chloroform / acetone (1 : 0-0 : 1), and 8 main parts were obtained. The pure chloroform part, 9: 1 chlorine / acetone Part and part of 8:2 chlorine / propane were subjected to silica gel column chromatography, and gradient elution was carr...
Embodiment 2
[0043] Physical and spectral data of compound 1 of the present invention:
[0044] Compound 1: white powder. [α] D 25 ‒41.4 ( c 0.11, MeOH); UV (MeOH) lambda max (log ε )216.0 (4.26) nm; IR (KBr) ν max 3452, 2944, 1709, 1615, 1453, 1368, 1246, 1168, 1079, 669 cm -1 ; 1 H and 13 C NMR data, see Table 1; HRESIMS m / z 307.1918 [M‒H] ‒ (calcd for C 18 h 27 o 4 , 307.1915).
[0045] Table 1 Compound 22 1 H NMR [ δ H (ppm), ( J Hz)] and 13 C NMR [ δ C (ppm)] Data a
[0046]
[0047] a Measured by Bruker Avance III-400 MHz nuclear magnetic resonance instrument, the chemical shift value is expressed in ppm, and the solvent is CD 3 COCD 3 .
Embodiment 3
[0049] Antimalarial activity detection of compounds of the present invention:
[0050] Using the internationally accepted 4-day inhibition test method, each mouse was inoculated intraperitoneally with 1×10 7 Plasmodium-infected red blood cells were given intragastric administration 3 hours after inoculation with Plasmodium, and then administered once every 24 hours for 4 consecutive days (the inoculation day was D 0 , the next day is D 1 , and so on), on day 5 (D 4 ) from the tail vein to collect blood, apply a thin blood film, fix with methanol, stain with Wright-Giemsa mixed staining method, and observe under a 10×100 oil microscope. If no Plasmodium asexual body is found after randomly checking 50 fields of view, it will be judged as negative, and if a positive thin blood film is randomly counted, 5 fields of view should be randomly counted, and the total number of red blood cells should not be less than 1000, and then the Plasmodium inhibition rate should be calculated a...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com